CHIT1 and anemia (phenotype): Miglustat is effective on the size of the liver and spleen as well as on the decrease of chitotriosidase levels, however its efficacy on hematological parameters is more limited and improvement takes longer (improvement of anemia after 24 months, little improvement of thrombocytopenia).